new BindingDB logo
myBDB logout

BDBM285597 3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 70::US9598421, Example 70

SMILES: Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F

InChI Key:

Data: 8 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 285597   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3


(Homo sapiens (Human))
BDBM285597
PNG
(3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyc...)
Show SMILES Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F |r,wU:20.22,22.26,(-3.54,.88,;-2.05,1.28,;-1.66,2.76,;-.17,3.16,;.23,4.65,;.92,2.07,;.52,.59,;-.96,.19,;-1.36,-1.3,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;1.08,-2.55,;1.85,-1.21,;1.85,-3.88,;3.39,-3.88,;4.73,-4.65,;4.73,-3.11,;5.5,-1.78,)|
PDB

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 36.4n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US10077269 (2018)


BindingDB Entry DOI: 10.7270/Q2P84DX5
More data for this
Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4B


(Homo sapiens (Human))
BDBM285597
PNG
(3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyc...)
Show SMILES Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F |r,wU:20.22,22.26,(-3.54,.88,;-2.05,1.28,;-1.66,2.76,;-.17,3.16,;.23,4.65,;.92,2.07,;.52,.59,;-.96,.19,;-1.36,-1.3,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;1.08,-2.55,;1.85,-1.21,;1.85,-3.88,;3.39,-3.88,;4.73,-4.65,;4.73,-3.11,;5.5,-1.78,)|
PDB

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 31n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US10077269 (2018)


BindingDB Entry DOI: 10.7270/Q2P84DX5
More data for this
Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform 1


(Homo sapiens (Human))
BDBM285597
PNG
(3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyc...)
Show SMILES Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F |r,wU:20.22,22.26,(-3.54,.88,;-2.05,1.28,;-1.66,2.76,;-.17,3.16,;.23,4.65,;.92,2.07,;.52,.59,;-.96,.19,;-1.36,-1.3,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;1.08,-2.55,;1.85,-1.21,;1.85,-3.88,;3.39,-3.88,;4.73,-4.65,;4.73,-3.11,;5.5,-1.78,)|
PDB

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 90n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US10077269 (2018)


BindingDB Entry DOI: 10.7270/Q2P84DX5
More data for this
Ligand-Target Pair
Phosphodiesterase 4D


(Homo sapiens (Human))
BDBM285597
PNG
(3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyc...)
Show SMILES Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F |r,wU:20.22,22.26,(-3.54,.88,;-2.05,1.28,;-1.66,2.76,;-.17,3.16,;.23,4.65,;.92,2.07,;.52,.59,;-.96,.19,;-1.36,-1.3,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;1.08,-2.55,;1.85,-1.21,;1.85,-3.88,;3.39,-3.88,;4.73,-4.65,;4.73,-3.11,;5.5,-1.78,)|
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.76E+3n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US9598421 (2017)


BindingDB Entry DOI: 10.7270/Q2K939KG
More data for this
Ligand-Target Pair
Phosphodiesterase 4A (PDE4)


(Homo sapiens (Human))
BDBM285597
PNG
(3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyc...)
Show SMILES Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F |r,wU:20.22,22.26,(-3.54,.88,;-2.05,1.28,;-1.66,2.76,;-.17,3.16,;.23,4.65,;.92,2.07,;.52,.59,;-.96,.19,;-1.36,-1.3,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;1.08,-2.55,;1.85,-1.21,;1.85,-3.88,;3.39,-3.88,;4.73,-4.65,;4.73,-3.11,;5.5,-1.78,)|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 36.4n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US9598421 (2017)


BindingDB Entry DOI: 10.7270/Q2K939KG
More data for this
Ligand-Target Pair
Phosphodiesterase 4B (PDE4B)


(Homo sapiens (Human))
BDBM285597
PNG
(3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyc...)
Show SMILES Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F |r,wU:20.22,22.26,(-3.54,.88,;-2.05,1.28,;-1.66,2.76,;-.17,3.16,;.23,4.65,;.92,2.07,;.52,.59,;-.96,.19,;-1.36,-1.3,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;1.08,-2.55,;1.85,-1.21,;1.85,-3.88,;3.39,-3.88,;4.73,-4.65,;4.73,-3.11,;5.5,-1.78,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 31n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US9598421 (2017)


BindingDB Entry DOI: 10.7270/Q2K939KG
More data for this
Ligand-Target Pair
Phosphodiesterase 4C


(Homo sapiens (Human))
BDBM285597
PNG
(3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyc...)
Show SMILES Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F |r,wU:20.22,22.26,(-3.54,.88,;-2.05,1.28,;-1.66,2.76,;-.17,3.16,;.23,4.65,;.92,2.07,;.52,.59,;-.96,.19,;-1.36,-1.3,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;1.08,-2.55,;1.85,-1.21,;1.85,-3.88,;3.39,-3.88,;4.73,-4.65,;4.73,-3.11,;5.5,-1.78,)|
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 90n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US9598421 (2017)


BindingDB Entry DOI: 10.7270/Q2K939KG
More data for this
Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4D


(Homo sapiens (Human))
BDBM285597
PNG
(3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyc...)
Show SMILES Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F |r,wU:20.22,22.26,(-3.54,.88,;-2.05,1.28,;-1.66,2.76,;-.17,3.16,;.23,4.65,;.92,2.07,;.52,.59,;-.96,.19,;-1.36,-1.3,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;1.08,-2.55,;1.85,-1.21,;1.85,-3.88,;3.39,-3.88,;4.73,-4.65,;4.73,-3.11,;5.5,-1.78,)|
PDB

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.76E+3n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US10077269 (2018)


BindingDB Entry DOI: 10.7270/Q2P84DX5
More data for this
Ligand-Target Pair